603520.SS

Zhejiang Starry Pharmaceutical Co.,Ltd. [603520.SS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

603520.SS Stock Summary

Top 10 Correlated ETFs

603520.SS


Top 10 Correlated Stocks

603520.SS


In the News

603520.SS Financial details

Company Rating
Buy
Market Cap
4.23B
Income
-61.76M
Revenue
2.39B
Book val./share
5.13
Cash/share
2.3
Dividend
0.2
Dividend %
1.53%
Employees
1.84K
Optionable
No
Shortable
Yes
Earnings
19 Apr 2024
P/E
-69.42
Forward P/E
8.95
PEG
5.84
P/S
1.88
P/B
2.44
P/C
5.13
P/FCF
-16.15
Quick Ratio
0.45
Current Ratio
0.82
Debt / Equity
1.83
LT Debt / Equity
0.46
-
-
EPS (TTM)
-0.18
EPS next Y
1.32
EPS next Q
-
EPS this Y
-122.34%
EPS next Y
-843.24%
EPS next 5Y
-843.24%
EPS last 5Y
NAN%
Revenue last 5Y
19.07%
Revenue Q/Q
5.61%
EPS Q/Q
-85.36%
-
-
-
-
SMA20
20%
SMA50
-14.29%
SMA100
-20%
Inst Own
-
Inst Trans
-
ROA
-1%
ROE
-4%
ROC
-0.02%
Gross Margin
23%
Oper. Margin
-2%
Profit Margin
-3%
Payout
-280%
Shs Outstand
342.51M
Shs Float
202.51M
-
-
-
-
Target Price
-
52W Range
7.86-19.37
52W High
-37.84%
52W Low
+68.71%
RSI
52
Rel Volume
0.97
Avg Volume
6.76M
Volume
6.55M
Perf Week
-10.46%
Perf Month
40.6%
Perf Quarter
-
Perf Half Y
-23.21%
-
-
-
-
Beta
0.486
-
-
Volatility
0.4%, 1.2%
Prev Close
-1.01%
Price
11.81
Change
-3.04%

603520.SS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
2.723.984.095.876.23
Net income per share
0.290.520.710.95-0.21
Operating cash flow per share
0.590.750.521.49-0.23
Free cash flow per share
0.090.350.060.6-1.61
Cash per share
0.531.292.782.481.94
Book value per share
2.723.035.466.385.16
Tangible book value per share
0.570.943.44.253.04
Share holders equity per share
2.723.035.466.385.16
Interest debt per share
5.836.586.515.818.4
Market cap
3.05B7.12B15.71B15.82B6.7B
Enterprise value
4.71B8.77B17B16.96B8.82B
P/E ratio
32.5941.8265.8348.87-93.12
Price to sales ratio
3.435.4411.57.913.14
POCF ratio
15.9128.8790.0731.1-85.46
PFCF ratio
103.7162.77737.3477.2-12.17
P/B Ratio
3.437.158.627.283.79
PTB ratio
3.437.158.627.283.79
EV to sales
5.296.712.438.484.14
Enterprise value over EBITDA
17.1219.9332.2426.4928.19
EV to operating cash flow
24.5735.5497.4233.32-112.52
EV to free cash flow
160.1377.28797.5682.72-16.02
Earnings yield
0.030.020.020.02-0.01
Free cash flow yield
0.010.0200.01-0.08
Debt to equity
2.072.091.140.881.58
Debt to assets
0.60.60.470.390.52
Net debt to EBITDA
6.033.742.431.776.78
Current ratio
0.770.771.271.090.79
Interest coverage
1.954.014.365.421.65
Income quality
2.011.350.691.541.09
Dividend Yield
0.040.020.010.010.03
Payout ratio
1.160.690.620.62-3.03
Sales general and administrative to revenue
0.050.040.050.030.03
Research and developement to revenue
0.070.060.060.060.06
Intangibles to total assets
0.240.210.170.160.14
Capex to operating cash flow
-0.85-0.54-0.88-0.66.02
Capex to revenue
-0.18-0.1-0.11-0.15-0.22
Capex to depreciation
-1.92-1.22-1.21-1.96-2.94
Stock based compensation to revenue
00000
Graham number
4.185.959.3611.684.94
ROIC
0.040.090.090.080.04
Return on tangible assets
0.040.060.060.08-0.02
Graham Net
-4.59-4.73-3.02-3.1-5.7
Working capital
-294.67M-362.64M407.83M175.75M-588.15M
Tangible asset value
186.4M307.26M1.14B1.45B1.04B
Net current asset value
-1.18B-1.23B-608.06M-619.03M-1.36B
Invested capital
2.072.091.140.881.58
Average receivables
295.28M343.91M398.6M568.11M711.9M
Average payables
141.73M257.95M295.45M443.44M565.79M
Average inventory
357.96M427.07M480.71M527.07M628.09M
Days sales outstanding
137.0198.6118.45126.4125.23
Days payables outstanding
152.13143.61141.06172.29121.9
Days of inventory on hand
295.58206.87255.75150.9166.53
Receivables turnover
2.663.73.082.892.91
Payables turnover
2.42.542.592.122.99
Inventory turnover
1.231.761.432.422.19
ROE
0.110.170.130.15-0.04
Capex per share
-0.5-0.41-0.46-0.89-1.38

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
1.792.21.771.621.6
Net income per share
-0.17-0.30.030.080.01
Operating cash flow per share
-0.17-0.30.03-0.010.28
Free cash flow per share
-0.66-0.49-0.22-0.270.14
Cash per share
2.961.942.441.682.3
Book value per share
7.625.165.575.475.13
Tangible book value per share
4.293.043.33.213.04
Share holders equity per share
7.625.165.575.475.13
Interest debt per share
11.358.219.549.319.47
Market cap
4.18B6.7B6.06B5.32B5.3B
Enterprise value
6.2B8.82B8.29B7.71B7.71B
P/E ratio
-26.04-16.57158.2551.73327.55
Price to sales ratio
9.628.8810.710.279.68
POCF ratio
-104.14-66.26633-2.94K55.5
PFCF ratio
-26.19-40.25-86.17-60.96114.16
P/B Ratio
2.263.793.413.053.01
PTB ratio
2.263.793.413.053.01
EV to sales
14.2611.6914.6514.8814.09
Enterprise value over EBITDA
-217.55152.2213.29174.44192.84
EV to operating cash flow
-154.42-87.24866.76-4.26K80.76
EV to free cash flow
-38.84-52.99-118-88.34166.12
Earnings yield
-0.01-0.02000
Free cash flow yield
-0.04-0.02-0.01-0.020.01
Debt to equity
1.481.581.71.691.83
Debt to assets
0.520.520.550.540.56
Net debt to EBITDA
-70.8336.657.5254.0660.32
Current ratio
0.850.790.820.730.82
Interest coverage
-0.39-3.460.381.040.29
Income quality
111-0.0723.61
Dividend Yield
0.01000.020
Payout ratio
-0.71-0.253.083.715.62
Sales general and administrative to revenue
0.17-0.050.0500.12
Research and developement to revenue
0.080.050.060.060.07
Intangibles to total assets
0.150.140.130.130.13
Capex to operating cash flow
2.980.65-8.3547.24-0.51
Capex to revenue
-0.27-0.09-0.14-0.16-0.09
Capex to depreciation
-2.69-1.47-1.8-1.930
Stock based compensation to revenue
00.01000
Graham number
5.325.851.943.151.17
ROIC
0-0.0200.010
Return on tangible assets
-0.01-0.0200.010
Graham Net
-7.51-5.7-6.3-6.93-6.4
Working capital
-403.16M-588.15M-517.73M-820.26M-544.24M
Tangible asset value
1.04B1.04B1.05B1.02B1.04B
Net current asset value
-1.24B-1.36B-1.39B-1.47B-1.45B
Invested capital
1.481.581.71.691.83
Average receivables
730.32M715.47M740.08M676.68M584.77M
Average payables
526.31M524.48M530M533.49M535.6M
Average inventory
705.86M750.91M762.47M897.98M1.04B
Days sales outstanding
144.987.26119.11105.0292.98
Days payables outstanding
129.3681.29103.92130.14116.12
Days of inventory on hand
194.23111.06157.34239.95237.29
Receivables turnover
0.621.030.760.860.97
Payables turnover
0.71.110.870.690.78
Inventory turnover
0.460.810.570.380.38
ROE
-0.02-0.060.010.010
Capex per share
-0.49-0.19-0.25-0.27-0.14

603520.SS Frequently Asked Questions

What is Zhejiang Starry Pharmaceutical Co.,Ltd. stock symbol ?

Zhejiang Starry Pharmaceutical Co.,Ltd. is a CN stock and trading under the symbol 603520.SS

What is Zhejiang Starry Pharmaceutical Co.,Ltd. stock quote today ?

Zhejiang Starry Pharmaceutical Co.,Ltd. stock price is $11.81 today.

Is Zhejiang Starry Pharmaceutical Co.,Ltd. stock public?

Yes, Zhejiang Starry Pharmaceutical Co.,Ltd. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Similar Market Cap